Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat
- PMID: 2123806
- DOI: 10.1007/BF00404137
Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat
Abstract
We investigated the role of the polyol pathway in the pathogenesis of glomerular basement membrane thickening in galactosaemic rats, an animal model that develops basement membrane lesions comparable to those of human diabetic subjects. Normotensive Wistar-Kyoto rats fed a 30% galactose diet for nine months developed significant glomerular basement membrane thickening by comparison with rats on a control test diet (p = 0.008). However, addition of an aldose reductase inhibitor, sorbinil (250 mg/kg diet), to the galactose diet did not prevent the increase in glomerular basement membrane thickness. Furthermore, by using a quantitative electron microscopic immunogold technique, we examined biochemical alterations in the composition of glomerular basement membranes in this animal model. The labelling density (comparable to relative concentration) of collagen type IV in thickened glomerular basement membranes of galactosaemic animals was significantly increased by comparison to those of control rats (p = 0.015). However, there was no significant difference in labelling densities of laminin and heparan sulfate proteoglycan core protein of these animals. Thus, our results indicate that an increase in glomerular basement membrane thickness accompanied by an increase in the labelling density of collagen type IV occurs in the galactosaemic rats, but this thickening is not prevented by sorbinil at the dose used in this experiment. Our study raises the strong possibility that glomerular basement membrane thickening in galactosaemic rats may not be due to excessive polyol pathway activity.
Similar articles
-
Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.Exp Eye Res. 1990 Mar;50(3):269-80. doi: 10.1016/0014-4835(90)90211-c. Exp Eye Res. 1990. PMID: 2108050
-
Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.J Diabet Complications. 1991 Oct-Dec;5(4):230-7. doi: 10.1016/0891-6632(91)90082-z. J Diabet Complications. 1991. PMID: 1779018
-
Aldose reductase activity and basement membrane thickening.Metabolism. 1986 Apr;35(4 Suppl 1):35-40. doi: 10.1016/0026-0495(86)90185-x. Metabolism. 1986. PMID: 3083207
-
Pericapillary basement membrane thickening in human skeletal muscles.Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H654-66. doi: 10.1152/ajpheart.00048.2016. Epub 2016 Jul 1. Am J Physiol Heart Circ Physiol. 2016. PMID: 27371680 Review.
-
Developmental biology of glomerular basement membrane components.Curr Opin Nephrol Hypertens. 1998 Jan;7(1):13-9. doi: 10.1097/00041552-199801000-00003. Curr Opin Nephrol Hypertens. 1998. PMID: 9442357 Review.
Cited by
-
Regulation of aldose reductase gene expression in renal cortex and medulla of rats.Diabetologia. 1995 Jan;38(1):46-54. doi: 10.1007/BF02369352. Diabetologia. 1995. PMID: 7744229
-
Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.Drugs. 1997 Aug;54(2):197-234. doi: 10.2165/00003495-199754020-00002. Drugs. 1997. PMID: 9257079 Review.
-
The role of polyols in the pathophysiology of hypergalactosemia.Eur J Pediatr. 1995;154(7 Suppl 2):S53-64. doi: 10.1007/BF02143805. Eur J Pediatr. 1995. PMID: 7671966 Review.
-
The link between hyperglycaemia and diabetic nephropathy.Diabetologia. 1992 Jun;35(6):499-504. doi: 10.1007/BF00400475. Diabetologia. 1992. PMID: 1612221 Review.